Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 183

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Immunogenicity of Cas9 Protein

Open access
Mehta, Aditi, Merkel, Olivia M. · 2020 · Journal of Pharmaceutical Sciences

Abstract

CRISPR form the adaptive immune system in archaea and bacteria and have been modified for genome engineering in eukaryotic cells. CRISPR systems contain two components, a guide RNA (sgRNA), which is a short RNA composed of a 20 nucleotide sequence that targets specific sites in the genomic DNA and a scaffold necessary for its binding to the CRISPR-associated endonuclease (Cas9). Because of its high efficiency and accuracy, the CRISPR-Cas9 genome editing based therapies are poised to treat a multitude of human diseases with a promise to target previously ‘undruggable’ proteins. As the first in body clinical trial with CRISPR-Cas9 is embarked upon, the risks associated with administering the genome editing machinery to patients become increasingly relevant. Recent studies have demonstrated an innate and adaptive cellular immune response to Cas9 in mouse models and the presence of anti-Cas9 antibodies and T-cells in human plasma. Preexisting immunity against therapeutic Cas9 delivery could decrease its efficacy in vivo and may pose significant safety issues. This review focusses on the immunogenicity of the Cas9 protein and summarizes potential approaches to circumvent the problem of immune recognition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.xphs.2019.10.003

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 183

Metadata

Authors
Mehta, A., & Merkel, O. M.
Venue
Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Published
2020-01
Volume
109
Issue
1
Pages
62-67
ISSN
0022-3549 (ISSN-L)
OpenAlex
W2978341767
Cited by
183
References
12
FWCI
4.08
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunogenicity of Cas9 Protein. https://app.cochat.ai/papers/10.1016/j.xphs.2019.10.003
The paper
Mehta, A., & Merkel, O. M. (2020). Immunogenicity of Cas9 Protein. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2019.10.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.